Press Releases Ypsomed Group

Burgdorf – The Ypsomed Group will also be securing its position as a technology leader in the field of injection and infusion systems well into the future.

Toward this end, the medical technology firm based in Burgdorf will be investing over 50 million Swiss francs in the coming years in the research and development of a new generation of injection and infusion systems: These systems support the administration of medications with intelligent electronic and software-based additional functions.

Go back